H63D Syndrome

Oslo Syndrome (in research still known as H63D Syndrome) is a worldwide health problem in the field of iron metabolism disorders. After scientists from all over the world joined together in 2019 to form the H63D Syndrome Consortium, the consensus paper "H63D Syndrome" was adopted at a meeting in Oslo in December 2019. On the occasion of the 2022 conference the syndrome was renamed Oslo Syndrome for clinical settings. It is available in bookshops for a symbolic price. Also free of charge directly from the consortium.